Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts\r\nin the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease\r\n(HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail\r\npathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an\r\neffective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis,\r\ncompared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is\r\neffective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there\r\nis evidence to support a correlation between HFMD and onychomadesis.
Loading....